In Vitro Activity of Telavancin Against Clinically Important Gram-Positive Pathogens From 69 U.S. Medical Centers (2015): Potency Analysis by U.S. Census Divisions

Microbial Drug Resistance - United States
doi 10.1089/mdr.2017.0022
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

In Vitro Activity of Telavancin Against Gram-Positive Clinical Isolates Recently Obtained in Europe

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2007English

Ceftaroline Activity Against Bacterial Pathogens Frequently Isolated in U.S. Medical Centers: Results From Five Years of the AWARE Surveillance Program

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2015English

In Vitro Activity of Ceftaroline Against Clinical Isolates of Streptococcus Pneumoniae Recovered in 43 U.S. Medical Centers During 2010-2011

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2012English

Comparative in Vitro Activities of Daptomycin and Vancomycin Against Resistant Gram-Positive Pathogens

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2000English

U.S. Census Bureau

Choice Reviews Online
1998English

i̇n Vitro Activity of Linezolid in Combination With Vancomycin, Teicoplanin, Fusidic Acid, and Ciprofloxacin Against Gram-Positive Pathogens

Turkiye Klinikleri Journal of Medical Sciences
Medicine
2010English

Telavancin: A Novel Semisynthetic Lipoglycopeptide Agent to Counter the Challenge of Resistant Gram-Positive Pathogens

Therapeutic Advances in Infectious Disease
2017English

In Vitro Activity of the Trinem Sanfetrinem (GV104326) Against Gram-Positive Organisms.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1996English

In Vitro Comparative Antimicrobial Activity of Cefpimizole Against Clinical Isolates From Five Medical Centers.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1985English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy